Focus: Empire Genomics specializes in high-throughput genome-wide analysis, positioned as a biotechnology tools and services provider. The company operates from Depew, NY with minimal disclosed scale metrics.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Recent layoff filing — 23 affected
Source: state DOL filings via Big Local News
No open roles listed right now. Follow Empire Genomics to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
No open positions listed yet.
Help build intelligence for Empire Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Empire Genomics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Source: USCIS H-1B Employer Data Hub
Absence of public risk signals (no WARN filings, FDA warnings, or shortage involvement) is neutral; however, lack of disclosure across all risk categories prevents deeper assessment.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo